![Carbamic acid,[[3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, buty…](https://static.cymitquimica.com/cas-image/thumb-webp/489433-carbamic-acid-3-4-1h-imidazol-1-ylmethyl-phenyl-5-2-methylpropyl-2-thienyl-sulfonyl-butyl-ester.webp)
CAS 477775-14-7
:Carbamic acid,[[3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, butyl ester
Description:
Carbamic acid, with the specific structure described, is a complex organic compound characterized by the presence of a carbamate functional group, which is derived from carbamic acid. This compound features a butyl ester moiety, indicating that it has a butyl group attached to the carbamic acid structure, enhancing its lipophilicity and potential biological activity. The presence of a thienyl group and an imidazolylmethyl phenyl substituent suggests that this compound may exhibit interesting pharmacological properties, possibly acting as a bioactive agent in medicinal chemistry. The sulfonyl group contributes to the compound's polarity and may influence its solubility and reactivity. Overall, the structural complexity of this compound implies potential applications in drug development, particularly in targeting specific biological pathways or receptors. However, detailed studies would be necessary to fully understand its properties, including its stability, reactivity, and biological interactions.
Formula:C23H29N3O4S2
InChI:InChI=1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27)
InChI key:XTEOJPUYZWEXFI-UHFFFAOYSA-N
SMILES:CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
BUTYL ((3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)-5-ISOBUTYLTHIOPHEN-2-YL)SULFONYL)CARBAMATE
CAS:BUTYL ((3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)-5-ISOBUTYLTHIOPHEN-2-YL)SULFONYL)CARBAMATEPurity:95%Molecular weight:475.6199951Butyl (3-(4-((1H-Imidazol-1-Yl)Methyl)Phenyl)-5-Isobutylthiophen-2-Yl)Sulfonylcarbamate
CAS:Butyl (3-(4-((1H-Imidazol-1-Yl)Methyl)Phenyl)-5-Isobutylthiophen-2-Yl)SulfonylcarbamateFormula:C23H29N3O4S2Purity:98%Molecular weight:475.62Butyl (3-(4-((1H-Imidazol-1-Yl)Methyl)Phenyl)-5-Isobutylthiophen-2-Yl)Sulfonylcarbamate
CAS:Formula:C23H29N3O4S2Purity:98%Color and Shape:SolidMolecular weight:475.6241Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate
CAS:Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamateFormula:C23H29N3O4S2Purity:98%Molecular weight:475.62AT2 receptor agonist C21
CAS:C21 is a potent and selective agonist of the AT2 receptor. It has been shown to have significant anti-inflammatory effects in vitro on human monocytes, macrophages, and neutrophils. C21 also inhibits TNF-α production by these cells. The compound has been shown to have no adverse effects on the viability of red blood cells or granule neurons in vivo, as well as no effect on epidermal growth factor (EGF) levels in mice. C21 is an organometallic compound with a chemical structure that includes a molybdenum atom linked to two hydroxyl groups, giving it a redox potential between +1.5 and +2 volts.Formula:C23H29N3O4S2Purity:Min. 95%Molecular weight:475.6 g/molBuloxibutid
CAS:Buloxibutid: a novel AT2 receptor agonist, Ki=0.4 nM (AT2), 10 μM (AT1).Formula:C23H29N3O4S2Purity:98.10% - 98.24%Color and Shape:Yellow SolidMolecular weight:475.624
